Showing results (91-100 of 97) with videos related to

Sort By:
Pageof 10
You have reached the last page of results.This site can display upto 97 results.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|July 1, 2014
[Treatment of non-neurogenic masculine urinary incontinence due to overactive bladder: a review by the LUTS committee of the French Urological Association]S Lebdai, O Haillot, A R Azzouzi, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|May 28, 2014
[Initial assessment of male non-neurogenic incontinence: systematic review of the literature by the LUTS committee of the French Urological Association]R Mathieu, A Benchikh, A R Azzouzi, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|September 13, 2014
[Conservative treatment of male non-neurologic urinary incontinence: a review by the LUTS committee of the French Urological Association]S Lebdai, N B Delongchamps, A R Azzouzi, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|December 9, 2015
[Medicoeconomic aspects of benign prostatic hyperplasia medical treatment]S Lebdai, A R Azzouzi, N-B Delongchamps, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|December 3, 2014
[Evaluation of the impact of CTMH guidelines on the management of benign prostatic hyperplasia]S Lebdai, A Rahmène Azzouzi, N B Delongchamps, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|May 31, 2002
[Standards, options, and recommendation for external radiotherapy of prostatic cancer: evaluation of the effect of dosage]P Pommier, A Villers, A Bataillard, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|January 19, 2002
[Standards, Options, and Recommendations for brachytherapy in patients with prostate cancer: efficacy and toxicity]P Pommier, A Villers, A Bataillard, et al.
Pageof 10